(Q78429131)

English

CJ-15,696 and Its Analogs, New Furopyridine Antibiotics from the Fungus Cladobotryum varium: Fermentation, Isolation, Structural Elucidation, Biotransformation and Antibacterial Activities.

scientific article published on 01 March 2012

In more languages

Statements

scholarly article

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

CJ-15,696 and Its Analogs, New Furopyridine Antibiotics from the Fungus Cladobotryum varium: Fermentation, Isolation, Structural Elucidation, Biotransformation and Antibacterial Activities. (English)

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

Hypomyces aurantius

1 reference

(2S)-2-[(E)-but-2-en-2-yl]-3,3-bis(hydroxymethyl)-5-phenyl-2,7-dihydrofuro[2,3-b]pyridin-4-one

1 reference

(2R,3S)-2-hydroxy-3-[(E,3R)-3-hydroxy-2-methylbut-1-enyl]-3-methyl-7-phenyl-2,5-dihydrofuro[3,2-c]pyridin-4-one

1 reference

(2R)-2-[(E)-but-2-en-2-yl]-3,3-bis(hydroxymethyl)-5-phenyl-2,7-dihydrofuro[2,3-b]pyridin-4-one

1 reference

1 reference

1 reference

1 reference

1 reference

(2R)-2alpha-[(E)-1-Methyl-1-propenyl]-3-methyl-3beta-(hydroxymethyl)-7-phenyl-2,3-dihydrofuro[3,2-c]pyridine-4(5H)-one

1 reference

(1R,9S,11R)-1,11,12-trimethyl-6-phenyl-8,10-dioxa-4-azatricyclo[7.4.0.02,7]trideca-2(7),5,12-trien-3-one

1 reference

(2R,3S)-2-hydroxy-3-[(E,3S)-3-hydroxy-2-methylbut-1-enyl]-3-methyl-7-phenyl-2,5-dihydrofuro[3,2-c]pyridin-4-one

1 reference

1 reference

(2R,3R)-2-[(E)-but-2-en-2-yl]-5-(4-hydroxyphenyl)-3-methyl-4-oxo-2,7-dihydrofuro[2,3-b]pyridine-3-carbaldehyde

1 reference

(2R,3S)-2-[(E)-4-hydroxybut-2-en-2-yl]-3-(hydroxymethyl)-3-methyl-5-phenyl-2,7-dihydrofuro[2,3-b]pyridin-4-one

1 reference

(2R,3R)-2-[(E)-4-hydroxybut-2-en-2-yl]-3-methyl-4-oxo-5-phenyl-2,7-dihydrofuro[2,3-b]pyridine-3-carbaldehyde

1 reference

Cunninghamella elegans

1 reference

1 reference

1 reference

author name string

SHINICHI SAKEMI

1

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

JON BORDNER

2

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

DEBRA L. DECOSTA

3

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

KOEN A. DEKKER

4

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

HIDEO HIRAI

5

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

TAISUKE INAGAKI

6

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

YOON-JEONG KIM

7

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

NAKAO KOJIMA

8

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

JEFFREY C. SIMS

9

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

YUTAKA SUGIE

10

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

AKEMI SUGIURA

11

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

JOYCE A. SUTCLIFFE

12

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

KIYOSHI TACHIKAWA

13

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

SUSAN J. TRUESDELL

14

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

JOHN W. WONG

15

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

NOBUJI YOSHIKAWA

16

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

YASUHIRO KOJIMA

17

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

publication date

2002

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/antibiotics1968/55/1/55_1_6/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.55.6?email=unpaywall_01@example.com

The Journal of Antibiotics

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

55

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

1

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

6-18

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.55.6?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Microbial transformation of immunosuppressive compounds. II. Specific desmethylation of 13-methoxy group of FK 506 and FR 900520 by an unidentified Actinomycete ATCC 53828 [corrected]

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.55.6

Antibiotic resistance in gram-positive bacteria: epidemiological aspects

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.55.6

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.55.6

Microbial models of mammalian metabolism

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.55.6

Cladobotryal: a fungal metabolite with a novel ring system

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.55.6

12 April 2024

https://opencitations.net/index/api/v1/citations/10.3891/ACTA.CHEM.SCAND.52-0631

Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.55.6

Identifiers

10.7164/ANTIBIOTICS.55.6

1 reference

10.7164/ANTIBIOTICS.55.6

https://api.crossref.org/v1/works/http://dx.doi.org/10.7164/antibiotics.55.6

14 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78429131&oldid=2128797446"